Navigation Links
Cephalon Reports Another Strong Quarter
Date:10/28/2008

CEPHALON, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

Nine Months Ended

September 30,

2008 2007

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income (loss) $210,962 $(235,886)

Adjustments to reconcile net

income to net cash provided by

operating activities:

Deferred income tax

(benefit) expense (9,409) 8,750

Shortfall tax benefits from

stock-based compensation (451) (222)

Depreciation and amortization 128,772 101,206

Stock-based compensation expense 32,543 34,940

Gain on sale of investment - (5,791)

Gain on forgiveness of debt - (5,319)

Loss on disposals of property

and equipment 2,740 2,873

Impairment charges 1,164 -

Other (396) 180

Changes in operating

assets and liabilities:

Receivables (74,258) (26,218)

Inventory (14,557) (1,881)

Other assets (99,008) (28,552)

Accounts payable and

accrued expenses 34,526 380,776

Other liabilities 70,
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Announces Strong Third Quarter Financial Results
7. Cephalon Submits Supplemental New Drug Application for FENTORA
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
10. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
11. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... SAN DIEGO and TORONTO, March 3, 2015 /PRNewswire/ - ... company developing new therapeutics and molecular diagnostics that target ... for the quarter and seventh-month period ended December 31, ... changed its fiscal year end from May 31 to ... periods we are reporting today are for the quarter ...
(Date:3/3/2015)... -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be ... Miami, FL on March 10, 2015 at ... Chief Financial Officer, will provide a corporate overview. ... Halozyme,s corporate website at www.halozyme.com , and a recording ... To access the live webcast, please log on to Halozyme,s ...
(Date:3/3/2015)... NASA astronaut Scott Kelly , who is making final ... living and working on the International Space Station, will be ... EDT Monday, March 9. Kelly will participate from ... weeks of his training. The interviews will be preceded at ... mission training and previous spaceflights. To schedule an ...
(Date:3/3/2015)... LEXINGTON, Ky. (PRWEB) March 03, 2015 ... aligning their schedules for one event: the Alltech REBELation ... USA, from May 17-20. Now in its 31st year, ... people from 70 countries, and the opportunity to join ... week, March 7 at 11:59 p.m. EST, at which ...
Breaking Biology Technology:Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12Halozyme Therapeutics To Present At The Barclays 2015 Global Healthcare Conference 2NASA Astronaut Scott Kelly Available for Interviews before One-Year Space Station Mission 2World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 2World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 3World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 4
... now available for Robocycler 96 temperature,cyclers ... ,Jason Capodanno Michael Rahilly ,Stratagene Cloning Systems, Inc. ... for RoboCycler , 96 temperature cyclers, ... Assembly for RoboCycler 96 cyclers is supplied,with a software ...
... robust, high-fidelity PCR,amplification , Holly Hogrefe Brad ... Janice Cline Frances Bai Jeff Amberg ... release of pfuturbo DNA polymerase,* , ,an improved version ... polymerase is a blend of cloned Pfu DNA,polymerase and ...
... , Novel Herculase Hotstart DNA polymerase results in greater ... , Michael Borns Brad Scott ... Stratagenes Herculase , ... enzyme for difficult PCR applications, particularly those involving long, , ...
Cached Biology Technology:Oil-Free PCR Using the Hot Top Assembly 2Oil-Free PCR Using the Hot Top Assembly 3Oil-Free PCR Using the Hot Top Assembly 4Oil-Free PCR Using the Hot Top Assembly 5Oil-Free PCR Using the Hot Top Assembly 6Oil-Free PCR Using the Hot Top Assembly 7Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 2Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 3Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 4Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 5Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 6Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 7Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 8Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 9Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 10Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase 11The Best Enzyme for the Toughest PCR Challenges Improved with New Hot-Start Feature 2The Best Enzyme for the Toughest PCR Challenges Improved with New Hot-Start Feature 3
(Date:3/3/2015)... , March 3, 2015 Cryoport, ... of advanced cryogenic logistics solutions for the ... stem cells, cell lines, clinical research organizations, ... today announced the expansion of its relationship ... ("Fred Hutch") Clinical Research Division with ...
(Date:3/2/2015)... Calif. , March 2, 2015 ... leading developer of human interface solutions, today announced ... that is designed to enable rapid and secure ... ID™ module for gaming is a turnkey solution ... the ability to quickly integrate fingerprint ID solutions ...
(Date:3/2/2015)... Ala. , March 2, 2015  Businesses ... processing. Data protection company Tharon Rankins Enterprises has ... that provides an ultra-safe way for businesses to ... their financial transactions. Beconux is ... Tharon Rankins Enterprises. Functioning similarly to an ATM ...
Breaking Biology News(10 mins):Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3Personal Data Protection Company Launches New Product 2
... the prospect of using nanoparticles in biomedical applications and ... of the miniscule materials. Scientists at the University of ... kinds of nanoparticles damage cell membranes—enough to cause cell ... prevented. , "If you're inventing these sorts of materials, ...
... (Ed : testosterone isn't a protein, it's a ... allows it to function properly. Now Stanford University scientists ... when a protein molecule attached to a gold nanoparticle ... the same principle as ordinary pH tests that measure ...
... and maintenance of human embryonic stem cells in the ... University of California, San Diego (UCSD) School of Medicine ... Published in the April 2005 issue of the journal ... enriched by a human protein called activin A are ...
Cached Biology News:Probing The Promise And Perils Of Nanoparticles 2Probing The Promise And Perils Of Nanoparticles 3Scientists develop new color-coded test for protein folding 2UCSD researchers maintain stem cells without contaminated animal feeder layers 2
... On-Demand Cytometry The Guava ... blue laser based multiparameter cytometer with built-in ... you can screen plates of cells and ... of manipulating multiple tubes or having the ...
... cDNA sequencing and finishing services are ... can perform large-scale 5' screening or ... Our considerable experience with large-scale genome ... Agencourt an ideal cDNA outsourcing solution. ...
Shotgun library construction and high-throughput DNA sequencing of microbial genomes, BACs, adenoviruses, phosmids and cosmids. LIMS tracking utilizing Geospiza's Finch system....
... antibody to human XAB2 (amino terminus) ... through its interaction with XPA. Immunoprecipitation experiments ... XAB2 interacts with the transcription-coupled repair-specific proteins ... RNA polymerase II. Microinjection experiments with XAB2 ...
Biology Products: